Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.028 | 0.9 |
mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |